POTENTIATION OF CANCER THERAPIES BY ZNF217 INHIBITION

摘要

Potentiation of Cancer Therapies by ZNF217 InhibitionABSTRACT OF THE DISCLOSUREThis invention provides methods, reagents and kits for treating cancer in a patient or subject, e.g., a human. Accordingly, the present methods can be used to monitor the efficacy of a cancer treatment and to treat cancer, e.g., by inhibiting the expression and/or activity of ZNF217 in a neoplastic cell.